Vaxtex Cotfab Limited
Vaxtex Cotfab Limited (VCL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
vaxtexcotfabltd.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 5 Cr | 0 Cr | 2 Cr |
| Operating expenses (approx.) | 5 Cr | 0.22 Cr | 2 Cr |
| EBITDA | -0.10 Cr | -0.22 Cr | -0.11 Cr |
| OPM % | -1.8% | — | -5.0% |
| Other income | 1 Cr | 0.46 Cr | 0.74 Cr |
| Interest | 0.06 Cr | 0.02 Cr | 0.02 Cr |
| Depreciation | 0.01 Cr | 0.01 Cr | 0.0087 Cr |
| Profit before tax | 0.89 Cr | 0.22 Cr | 0.60 Cr |
| Tax % | -47.7% | 0.0% | 3.9% |
| Net profit | 1 Cr | 0.22 Cr | 0.57 Cr |
| EPS (₹) | ₹0.07 | ₹0.01 | ₹0.03 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 5 Cr | Sign in for TTM |
| Operating expenses (approx.) | 6 Cr | Sign in for TTM |
| EBITDA | -0.50 Cr | Sign in for TTM |
| OPM % | -9.5% | Sign in for TTM |
| Other income | 1 Cr | Sign in for TTM |
| Interest | 0.11 Cr | Sign in for TTM |
| Depreciation | 0.10 Cr | Sign in for TTM |
| Profit before tax | 0.41 Cr | Sign in for TTM |
| Tax % | -114.7% | Sign in for TTM |
| Net profit | 0.88 Cr | Sign in for TTM |
| EPS (₹) | ₹0.05 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 18 Cr |
| Reserves | -0.03 Cr |
| Borrowings | 11 Cr |
| Other liabilities | 19 Cr |
| Total liabilities | 48 Cr |
| Fixed assets (net) | 1 Cr |
| CWIP | 0 Cr |
| Investments | 8 Cr |
| Loans & advances | 10 Cr |
| Trade receivables | 14 Cr |
| Cash & bank | 0.0048 Cr |
| Other assets | 16 Cr |
| Total assets | 48 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 1 Cr |
| Cash from investing | -0.76 Cr |
| Cash from financing | -0.49 Cr |
| Net cash flow | -0.02 Cr |
| Free cash flow (OCF − Capex) | 1 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 1.8% |
| ROE % | 4.8% |
| Debtor days | 969 |
| Inventory days | 0 |
| Days payable | 1268 |
| Cash conversion cycle | -299 |
| Debt / equity | 0.61 |
| Current ratio | 1.80 |
| Net debt / EBITDA | — |